SCHEMBL19123777

SCHEMBL19123777

COc1ccc(-c2snc(-c3ccccc3C)c2C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NR1H4 Q96RI1 1/20 0.41
GFER P55789 1/20 0.40
ATM Q13315 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
ALOX5 P09917 1/20 0.40
PDE5A O76074 1/20 0.39
TP53 P04637 1/20 0.39
PPARD Q03181 2/20 0.39
PTGS2 P35354 2/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
GRM5 P41594 1/20 0.38
GRM1 Q13255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19123731 0.89 L3MBTL1 (0.50) MAPTALDH1A1MEN1KMT2ANR1H4
SCHEMBL17845084 0.87 GPBAR1 (0.44) MAPTALDH1A1MEN1KMT2AGFER
SCHEMBL19123932 0.82 CNR1 (0.43) MAPTALDH1A1NR1H4CNR1CNR2
SCHEMBL17736160 0.79 ALDH1A1 (0.46) MAPTALDH1A1ALOX5PTGS2HPGD
SCHEMBL17845090 0.76 L3MBTL1 (0.49) MAPTALDH1A1MEN1KMT2AATM
SCHEMBL16048703 0.76 ALDH1A1 (0.46) MAPTALDH1A1PTGS2HPGDRECQL
SCHEMBL899644 0.73 BACE1 (0.52) MAPTALDH1A1PTGS2HPGDRECQL
SCHEMBL17845139 0.70 CNR1 (0.43) MAPTKMT2AL3MBTL1CNR1CNR2
SCHEMBL17736158 0.70 GRM6 (0.42) MAPTALDH1A1MEN1KMT2AATM
SCHEMBL17736162 0.70 L3MBTL1 (0.52) MAPTALDH1A1ATML3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9845291-B2 Estrogen receptor modulators and uses thereof GENENTECH, INC. (US) 2017-12-19 US disclosed
US-20170197915-A9 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF GENENTECH, INC. (US) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170197915-A9 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ESR2, ESR1, GPER1 MAPT 256/4885ALDH1A1 1405/4885MEN1 2510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.